Todd Harris - Sep 15, 2023 Form 4 Insider Report for Tyra Biosciences, Inc. (TYRA)

Role
President and CEO, Director
Signature
/s/ Ali D. Fawaz, Attorney-in-Fact
Stock symbol
TYRA
Transactions as of
Sep 15, 2023
Transactions value $
$9,349
Form type
4
Date filed
9/19/2023, 07:36 PM
Previous filing
Aug 1, 2023
Next filing
Feb 6, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TYRA Common Stock Award $9.35K +1.42K +0.09% $6.58 1.6M Sep 15, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired under the Issuer's 2021 Employee Stock Purchase Plan.